# Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma

> **NCT00005057** · PHASE1 · COMPLETED · sponsor: **National Human Genome Research Institute (NHGRI)**

## Conditions studied

- Melanoma (Skin)

## Interventions

- **BIOLOGICAL:** adenovirus RSV-TK
- **DRUG:** ganciclovir

## Key facts

- **NCT ID:** NCT00005057
- **Lead sponsor:** National Human Genome Research Institute (NHGRI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-03
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2015-04-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005057, "Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00005057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*